neuroinflammation and alzheimer's pathology in pocd

Conditions: Post-Operative Confusion; Neuroinflammatory Response; Alzheimer Disease

Summary: the purpose of this project is to investigate the role of both neural inflammation and pre-existing neurodegenerative pathology in the risk and pathogenesis of post-operative cognitive dysfunction (pocd). to achieve this goal, the investigators will combine blood and cerebrospinal fluid (csf) sampling, standardized cognitive tests, and dynamic neurophysiological markers of cortical network dysfunction in the form of event-related potentials (erps), to assess the link between neurodegeneration and neuroinflammation in the pathogenesis of pocd.

the purpose of this project is to investigate the role of both neural inflammation and pre-existing neurodegenerative pathology in the risk and pathogenesis of post-operative cognitive dysfunction (pocd) in 120 patients who will undergo a total knee arthroscopy. the investigators will also explore neuropsychological, functional and biological measures as pre-operative risk indicators. to achieve this goal, the investigators will combine blood and cerebrospinal fluid (csf) sampling, standardized cognitive tests, and dynamic neurophysiological markers of cortical network dysfunction in the form of event-related potentials (erps), to assess the link between neurodegeneration and neuroinflammation in the pathogenesis of pocd. to separate potential effects of general anesthesia from those of neuroinflammation, the investigators will recruit patients undergoing total knee replacement with the use of sedation and spinal anesthesia. to address the age risk factor, the investigators are targeting patients ages 60 and older. by using both validated and experimental biomarkers, this novel study design will isolate the effects of pocd due to systemic and neural inflammation and examine the links to pre-surgical cognitive impairment and underlying neurodegeneration as susceptibility factors. baseline (on the day of their final preoperative surgical visit prior to their tka) the plan is to collect: 1. cognitive assessments a. montreal cognitive assessment b. stroop test c. symbol digit modalities test d. oral trail making test 2. collect two 4-ml blood samples for biomarker evaluation visit 2 pre-op (day of scheduled tka surgery) the plan is to collect: 1. repeat cognitive testing a. montreal cognitive assessment b. stroop test c. symbol digit modalities test d. oral trail making test 2. collect two 4-ml blood samples for biomarker evaluation 3. collect 2cc of cerebral spinal fluid visit 2 post-op: 1. 4 at test for delirium 2. collect two 4ml blood samples will be taken visit 3 (forty-eight hours after discharge): 1. brief cognitive testing via telephone or video conferencing. 1. blind montreal cognitive assessment 2. oral trail making test visit 4 (two weeks for their post-operative visit): 1. repeat cognitive testing 1. montreal cognitive assessment 2. stroop test 3. symbol digit modalities test 2. oral trail making test 3. collect two 4ml blood samples for biomarker testing. for patients who had pre-operative cognitive impairment, their participation in the study will end here for 20 participants with no indication of pre-surgical cognitive impairment (10 with no post-operative impairment and 10 with presumed pocd) visit 5 (\~ 6 weeks post-op) the plan is to collect: 1. complete initial neurophysiological recording of event-related potentials (erps). this erp session is performed to establish baseline cortical network function. neurophysiological studies will be conducted using a 128-electrode eeg system. 2. collect two 4-ml blood samples visit 6 end of study (at 6 months): 1. collect a final assessment of cognition 2. erp assessment

Eligibility criteria:
inclusion criteria: * males and females 60 years or older in age * subjects scheduled to undergo tka * fluent and literate in english * able to give consent for themselves based upon the macarthur competence assessment tool for clinical research * able to have a subarachnoid block with only intravenous sedation exclusion criteria: * less than 60 years of age * cognitively impaired to the point where they are unable to give consent for themselves * blindness or partial blindness * pre-existing neurodegenerative conditions * contraindication for subarachnoid block and/or requiring general anesthesia

Keywords: pocd neuroinflammation